Inventor
BANCEL STEPHANE
US31 patents
⚠️ This page may combine multiple inventors who share the name “BANCEL STEPHANE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MODERNATX INC
15 patentsUS9597380B2Mar 21, 2017
Terminally modified RNA
MODERNATX INC143 citations99
US10772975B2Sep 15, 2020
Modified Polynucleotides for the production of biologics and proteins associated with human disease
MODERNATX INC37 citations98
US9878056B2Jan 30, 2018
Modified polynucleotides for the production of cosmetic proteins and peptides
MODERNATX INC33 citations98
US10155029B2Dec 18, 2018
Terminally modified RNA
MODERNATX INC12 citations92
US9937233B2Apr 10, 2018
Engineered nucleic acids and methods of use thereof
MODERNATX INC12 citations92
US9814760B2Nov 14, 2017
Modified polynucleotides for the production of biologics and proteins associated with human disease
MODERNATX INC15 citations92
US10022425B2Jul 17, 2018
Engineered nucleic acids and methods of use thereof
MODERNATX INC13 citations91
US9828416B2Nov 28, 2017
Modified polynucleotides for the production of secreted proteins
MODERNATX INC3 citations84
US10858647B2Dec 8, 2020
Removal of DNA fragments in mRNA production process
MODERNATX INC8 citations82
US10138507B2Nov 27, 2018
Manufacturing methods for production of RNA transcripts
MODERNATX INC6 citations73
US11377470B2Jul 5, 2022
Ribonucleic acid purification
MODERNATX INC5 citations72
US10751386B2Aug 25, 2020
Engineered nucleic acids and methods of use thereof
MODERNATX INC2 citations72
US10077439B2Sep 18, 2018
Removal of DNA fragments in mRNA production process
MODERNATX INC3 citations71
US12023371B2Jul 2, 2024
Terminally modified RNA
MODERNATX INC0 citations62
US11845772B2Dec 19, 2023
Ribonucleic acid purification
MODERNATX INC1 citations62
MODERNA THERAPEUTICS INC
12 patentsUS9675668B2Jun 13, 2017
Modified polynucleotides encoding hepatitis A virus cellular receptor 2
MODERNA THERAPEUTICS INC109 citations99
US9587003B2Mar 7, 2017
Modified polynucleotides for the production of oncology-related proteins and peptides
MODERNA THERAPEUTICS INC67 citations99
US9572896B2Feb 21, 2017
In vivo production of proteins
MODERNA THERAPEUTICS INC75 citations99
US9254311B2Feb 9, 2016
Modified polynucleotides for the production of proteins
MODERNA THERAPEUTICS INC126 citations99
US9221891B2Dec 29, 2015
In vivo production of proteins
MODERNA THERAPEUTICS INC113 citations99
US9181319B2Nov 10, 2015
Engineered nucleic acids and methods of use thereof
MODERNA THERAPEUTICS INC94 citations99
US9572897B2Feb 21, 2017
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
MODERNA THERAPEUTICS INC65 citations98
US9504734B2Nov 29, 2016
Modified polynucleotides for the production of nuclear proteins
MODERNA THERAPEUTICS INC56 citations98
US9464124B2Oct 11, 2016
Engineered nucleic acids and methods of use thereof
MODERNA THERAPEUTICS INC188 citations98
US9447164B2Sep 20, 2016
Engineered nucleic acids and methods of use thereof
MODERNA THERAPEUTICS INC15 citations92
US9827332B2Nov 28, 2017
Modified polynucleotides for the production of proteins
MODERNA THERAPEUTICS INC7 citations84
US9782462B2Oct 10, 2017
Modified polynucleotides for the production of proteins associated with human disease
MODERNA THERAPEUTICS INC7 citations84